Shared insight on the optimal management of patients who have macular edema following retinal vein occlusion.
Peers & Perspective
Jennifer B. Green, MD, and Dennis Bruemmer, MD, PhD, have a conversation on the rise of Type 2 diabetes worldwide, and the available and upcoming treatment options.
A panel of experts discuss the best ways to treat peripheral arterial disease after revascularization.
Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, and Douglas DiRuggiero, DMSc, PA-C, discuss the management of atopic dermatitis with a focus on newer agents, including JAK inhibitors, currently in the drug approval pipeline.
Recommendations for properly treating pediatric and adult patients with inflammatory bowel disease based on common changes to the disease trajectory and it’s progressive nature.
James Januzzi, MD, and Javed Butler, MD, MPH, MBA, review recent updates in the recommendations for optimal medical care for patients with heart failure with reduced ejection fraction.
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
3
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
4
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
5